EP2069015A2 - Lampe zur stimulierung der produktion von vitamin d und verfahren zu ihrer herstellung - Google Patents

Lampe zur stimulierung der produktion von vitamin d und verfahren zu ihrer herstellung

Info

Publication number
EP2069015A2
EP2069015A2 EP07837496A EP07837496A EP2069015A2 EP 2069015 A2 EP2069015 A2 EP 2069015A2 EP 07837496 A EP07837496 A EP 07837496A EP 07837496 A EP07837496 A EP 07837496A EP 2069015 A2 EP2069015 A2 EP 2069015A2
Authority
EP
European Patent Office
Prior art keywords
vitamin
lamp
production
person
photons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07837496A
Other languages
English (en)
French (fr)
Inventor
Dennis L. Batchos
Patricia E. Reykdal
Donald L. Smith
John Tulk
Original Assignee
Voltarc Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Voltarc Technologies Inc filed Critical Voltarc Technologies Inc
Publication of EP2069015A2 publication Critical patent/EP2069015A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J61/00Gas-discharge or vapour-discharge lamps
    • H01J61/70Lamps with low-pressure unconstricted discharge having a cold pressure < 400 Torr
    • H01J61/72Lamps with low-pressure unconstricted discharge having a cold pressure < 400 Torr having a main light-emitting filling of easily vaporisable metal vapour, e.g. mercury
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/66Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing germanium, tin or lead
    • C09K11/666Aluminates; Silicates
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/66Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing germanium, tin or lead
    • C09K11/667Borates
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/70Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus
    • C09K11/71Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus also containing alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/74Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing arsenic, antimony or bismuth
    • C09K11/75Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing arsenic, antimony or bismuth containing antimony
    • C09K11/76Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing arsenic, antimony or bismuth containing antimony also containing phosphorus and halogen, e.g. halophosphates
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7766Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals
    • C09K11/778Borates
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7783Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals one of which being europium
    • C09K11/7794Vanadates; Chromates; Molybdates; Tungstates
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7783Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals one of which being europium
    • C09K11/7795Phosphates
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J61/00Gas-discharge or vapour-discharge lamps
    • H01J61/02Details
    • H01J61/38Devices for influencing the colour or wavelength of the light
    • H01J61/42Devices for influencing the colour or wavelength of the light by transforming the wavelength of the light by luminescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0614Tanning
    • A61N2005/0615Tanning using UV light sources having a specific spectrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661Radiation therapy using light characterised by the wavelength of light used ultraviolet

Definitions

  • the present invention relates generally to discharge lamps that stimulate the production of vitamin D in a person exposed thereto, and more specifically, to discharge lamps which over a predetermine exposure period stimulate a person's production of vitamin D without causing significant facultative pigmentation or melanin oxidization. Moreover, the present invention is also directed to discharge lamps that in addition to stimulating a person's production of vitamin D, emit photons that rejuvenate the collagen/elastin matrix that supports the person's skin, cartilage and bone.
  • vitamin D is considered to be a beneficial nutrient for bone-related conditions, such as rickets and osteoporosis. Additionally, it is now appreciated that diverse diseases including cancer, diabetes, multiple sclerosis, and coronary heart disease are also vitamin D mediated.
  • Vitamin D is a nutrient most people get though exposure to sunlight.
  • cholecalciferol (vitamin D 3 )
  • cholecalciferol is processed by the liver to create 25-dihydroxyvitamin D 3 which is later transformed by the kidneys to 1,25 dihydroxyvitamin D 3 .
  • the nutrient 1,25 dihydroxyvitamin D 3 is known to improve calcium absorption in the small intestines, improve urinary calcium re-absorption in the kidneys and improve bone mineralization.
  • those at greatest risk of having too little vitamin D include: elderly people; babies who are exclusively breast-fed; people with dark skin (darker- skinned people need more sun exposure to produce vitamin D); people who don't get any sun exposure (those who are housebound or who cover their bodies with clothing for religious or cultural reasons); people who live in the northern U.S. and Canada (e.g., above 37 degrees latitude) during the winter.
  • the vitamin D-effective photons packets of light energy
  • photons packets of light energy
  • i.e., those responsible for stimulating the cutaneous production of pro-vitamin D are found in the wavelengths between 250 nm and 320 nm, with 296 nm being the "peak" wavelength.
  • the utility of the action spectra illustrated in Fig. 1 will be discuss in more detail hereinbelow.
  • vitamin D occurs naturally in only a few food products and is added to just a handful of others, many experts worry that Americans get too little vitamin D to reap these potential benefits. Yet few are willing to encourage sun exposure with its well-known dangers and therefore, advocated vitamin supplements as a means for addressing vitamin D deficiencies.
  • UVR producing lamps emit a spectrum of ultraviolet light which is similar to that of the sun.
  • the sun emits three kinds of ultraviolet (UV) rays, UVA, UVB and UVC.
  • UVC at 100 nanometers (nm) to 280 nm, is the shortest and widely considered to be the most harmful wavelength of UV rays, but it is virtually blocked by the Earth's ozone layer and pollution.
  • UVB is the medium wavelength, from 280- 320 nm, and although overexposure to UVB has been found to cause erythema (sunburn), a controlled amount is necessary to initiate tanning in the skin.
  • UVA is the longest wavelength, from 320-400 nm, and has been found to be responsible for the completion of the tanning process (i.e., via oxidation or darkening of the pigment (melanin), as discussed in further detail herein).
  • Short-wavelength UVB (280-315 nm) has been recognized for some time as carcinogenic in experimental animals, and there is some evidence that longer-wavelength UVA (315-400 nm), which penetrates more deeply into the skin, also contributes to the induction of cancer.
  • the beneficial wavelengths i.e., those that stimulate the production of vitamin D
  • the harmful wavelengths hose that damage the skin and cause Cutaneous Malignant Melanoma (CMM) are found so close together that the electromagnetic spectrum has been described as "Mother Nature's little joke.”
  • dermatologist have resisted recommending any exposure to sunlight or UVR due to their position that UVR induces CMM.
  • the wavelengths associated with the biological reactions that stimulate the production of these protein are found between 580nm and 680nm and these wavelengths are also immunostimulatory (i.e., they stimulate our immune defense system).
  • a discharge lamp adapted for stimulating the production of vitamin D in human skin being exposed thereto, and more specifically, to discharge lamps which over a predetermine exposure period stimulate the production of Vitamin D without causing significant oxidation of a melanin or facultative pigmentation.
  • a novel discharge lamp that in addition to stimulating a person's production of vitamin D, emits photons that rejuvenate the collagen/elastin matrix that supports the person's skin, cartilage and bone.
  • the subject invention is directed to new and useful discharge lamps that solve the problems described above.
  • the present invention relates generally to mercury vapor discharge lamps of the fluorescent type having a particular phosphor coating(s) that is/are adapted to emit radiation having a preferred spectra when excited by the UV radiation generated from the mercury vapor discharge.
  • Lamps constructed in accordance with the present disclosure stimulate the production of Vitamin D without causing significant oxidation of a melanin or facultative pigmentation.
  • the present invention is also directed to lamps for stimulating vitamin
  • An embodiment of the novel lamp construction disclosed herein includes, inter alia, a vitreous tube having an outer periphery and axially opposed first and second ends which define an axial length for the tube therebetween.
  • the lamp further includes a first electrode assembly associated with the first end of the tube and a second electrode assembly associated with the second end of the tube.
  • a coating is applied on an interior of the tube which is adapted for delivering an effective dose of vitamin D photons to a person's skin during a predetermined exposure period, wherein the coating delivers an insufficient amount of UVB and UVA photons during the exposure period to cause significant facultative pigmentation and/or melanin oxidization.
  • the lamp of the present invention does not need to be elongated or axial in construction and can be formed in various shapes and sizes, such as circular or U-shaped, without departing from the inventive aspects of the present disclosure.
  • the exposure time required to deliver an effecting dose of vitamin D photons to a person's skin is less than T e and T m .
  • the ultraviolet radiation emitted from the lamp in a range of about 320 nm to about 340 nm is less than or equal to about 10 percent of the ultraviolet radiation emitted from the lamp in a range of about 280 nm to about 400 nm.
  • the lamp of the present invention is adapted for stimulating the production of collagen through emission of optimal energy in the 580nm to 680nm wavelengths.
  • the phosphor coating is also adapted for emitting photons that rejuvenate the collagen/elastin matrix that supports the person's skin, cartilage and bone.
  • the lamp of the present invention emits energy having a peak spectrum of 296 nm and a band with of 5nm.
  • Fig. 1 is a graphical comparison of two vitamin D-effective action spectra that illustrates a peak wavelength for both spectra occurring at 296nm;
  • Fig. 2 is a graphical comparison of the spectral distribution for three
  • UVR sources
  • Fig. 3 provides a graphical representation of the an action spectrum for skin rejuvenation
  • Figs. 4a-4f provides in tabular form the irradiance data for the Vitamin
  • Exemplary lamps constructed in accordance with the present invention provide a controlled amount of UVB radiation in the approximate 280 nm to 320 nm UV region of the spectrum, dramatically reduce the amount of UVA radiation in the approximate 340 nm to 400 nm UV region of the spectrum (hereinafter referred to as being "UVAl”), and virtually eliminate the amount of UV radiation in the approximate 320 nm to 340 nm UV region of the spectrum (hereinafter referred to as being "UVA2”) in comparison with prior UVR emitting discharge lamps.
  • UVAl the amount of UVA radiation in the approximate 280 nm to 320 nm UV region of the spectrum
  • UVA2 virtually eliminate the amount of UV radiation in the approximate 320 nm to 340 nm UV region of the spectrum
  • Lamps constructed in accordance with the teachings of the present invention provide light of an appropriate spectrum to induce the production of Vitamin D in the skin of the person being exposed to the light source.
  • Light between the wavelengths of 250 and 320 nm and particularly between 290 and 310 nm are those that stimulate the production of vitamin D in the skin. (See Fig. 1) This is also in the part of the spectrum that causes the skin to redden and sunburn so it is essential that the exposure be controlled.
  • a pure UVB phosphor were used in this application the person being exposed to the light would be overexposed in a matter of seconds.
  • the UVB phosphor is diluted with a non-UV emitting substance, such as a phosphor that gives off only visible light.
  • the UVAl (340 - 400 nm) photons are be kept to a minimum and the UV A2 (320 - 340 nm) kept near zero.
  • the phosphor combination has a peak spectrum of 296 nm and have a total band width of five nanometers and a visible phosphor that has no output below 420 nm.
  • lamps which achieve the desired spectral characteristics have been constructed using (Ca 5 Zn) 3 (PO 4 ) ⁇ Tl (NP803) as the UVB source and Ca 5 (F,CL)(PO 4 ) 3 :Sb:Mn (Cool White and Daylight) or (Sr 5 Mg) 3 (PO 4 ): Sn (Type 283) as the visible source.
  • the redder phosphors give better results because they have no output below 420 nm.
  • the NP803 peaks at 319 nm which is really too high but this phosphor has a tail that reaches below 290 nm so it has an output in the desired range of 290 to 310 nm.
  • UVB phosphors that work well in this application are MgSrAl ⁇ Oi 7 :Ce (Type 2096), Sr(BO 2 ) 6 :Pb (Type 2061) or (Ba,Zn,Mg)SiO 2 :Pb (Type 2071).
  • the visible phosphor does not have an output below 420nm.
  • Another criterion is that the visible phosphor must have little or no absorption above 290nm.
  • red phosphors are best suited for these applications, such as Y(P,V)O 4 :Eu (NP310), Gd(Zn,Mg)B 5 Oi 0 :Ce,Mn (L165), (Sr 5 Mg) 3 (PO 4 ): Sn (Type 283), CaSiO 3 :Pb,Mn (Type 290C), (Sr,Mg) 3 (PO4) 2 :Sn (Type 282), Ca 5 (F,CL)(PO 4 ) 3 :Sb:Mn (Type 4300).
  • the ratio of visible light emitting phosphor to UVB emitting phosphor is 93:7
  • the ratio can be 92.5:7.5 (e.g. Warm White phosphor (Type 4300 - NP803), or 76:24 (e.g., Orange (Type 283 - NP803)).
  • the amount of non-UV or visible light emitting phosphor added to the phosphor composition is based on the particular UVB emitting phosphor used and the proportions are adjusted in order to achieve the desired spectral irradiance for the lamp.
  • Fig. 2 provides a graphical comparison of the spectral distribution patterns of three UVR sources; a lamp constructed in accordance with the teachings of the present application (identified as, "Rxd-Orange”); a traditional IOOW sunlamp and natural sunlight at noon on a typical Midwestern summer day.
  • the phosphors used in the Rxd-Orange lamp have shifted a large portion of the photons to the left in the irradiance spectrum (to a lower wavelength) and into the vitamin D target range (i.e., Region 1: 250 nm to 320nm).
  • the tanning photons (Region 2: 340nm to 430nm) that are typically within the Region 2 on the graph, have been virtually eliminated.
  • Table 2 below compares the UV irradiance data of the RxD lamp to a traditional sunlamp, identified as "GTX65 Blue.”
  • a larger percentage of the total UV irradiance UVA & UVB
  • UVA & UVB percentage of UV irradiance
  • the RxD(orange) sunlamp shows an increase in vitamin D-eff photons of 122% and 330% over sunlight at noon on a typical Midwestern summer day.
  • the tanning power the RxD sunlamp, reduces the tanning power by 91.5% as compared to traditional sunlamps and by 87.2% as compared to sunlight.
  • the RxD lamp is more efficient stimulator of vitamin D then either of the other sources and has virtually removed all of the photons associated with facultative pigmentation.
  • Te and Tt-eff are calculated. More specifically, skilled artisans in the field of UV discharge lamps will readily understand how the "source" readings/spectral irradiance for a discharge lamp, measured for example by a scanning double-beam spectroradiaometer, are converted into Te and Tt-eff. The vitamin D effective (vD-eff) value is determined in a similar manner.
  • the irradiance at each wavelength is multiplied by a corresponding weighing factor provided by the appropriate action spectrum, such as Fig. 1 for vitamin D stimulation and Fig. 3 for collagen rejuvenation, to determine "weighted” or "effective” values.
  • a corresponding weighing factor provided by the appropriate action spectrum, such as Fig. 1 for vitamin D stimulation and Fig. 3 for collagen rejuvenation, to determine "weighted” or "effective” values.
  • a total effective irradiance is obtained through integration of the data using the FDA EAS formula.
  • UVB (280-320nm) 0.0003048 0.000535 0.0002206
  • UVA (320-400nm) 0.0006499 0.0144104 0.0040635
  • UVA1 (340-400nm) 0.0003833 0.01 15042 0.0033147
  • UVA2 (320-340nm) 0.0002666 0.0029062 0.0007488
  • UVA (320-400nm) 68.1 96.4 94.9
  • UVA1 (340-400nm) 40.1 77 77.4
  • UVA2 (320-340nm) 27.9 19.5 17.5
  • UVI Ultraviolet Index
  • the total irradiance in the UVAAJVB range for RxD lamp is much less than the other two sources and many of the photons that would normally be found in the UVAl and UV A2 ranges have been shifted into the UVB range.
  • vitamin D-effective When we speak of a "vitamin D-effective" (usually shortened to vitamin D-eff or vD-eff) dose, we are referring to a level (Wm ⁇ 2 or mW/m'2) that is determined after the "source (i.e., sunlight or a sunlamp) irradiance (that has been determined by a scanning double beam spectroradiometer such as our Optronics Laboratory 752/754/756 has been convoluted (i.e., multiplied by) with a vitamin D AS (action spectrum).
  • source i.e., sunlight or a sunlamp
  • the SPI action spectrum results in a more conservative exposure time, thus reducing the chance of any ill effects on the person exposed to the lamp.
  • the wavelengths associated with the biological reactions that stimulate the production of collagen and elastogen i.e., the proteins that provide the "matrix" that supports our skin, cartilage and bones (that makes possible younger looking skin) and that breaks down as we age are found between 580 nm and 680 nm. (See Fig. 3) and these wavelengths are also immunostimulatory (i.e., they stimulate our immune defense system).
  • the present inventors have added a phosphor to the phosphor blend in certain embodiments which emits photons in the 580 nm and 680 nm range, (e.g. Osram Type 283, Type 290 & Type L 165 or Nichia NP310).
  • a phosphor to the phosphor blend in certain embodiments which emits photons in the 580 nm and 680 nm range, (e.g. Osram Type 283, Type 290 & Type L 165 or Nichia NP310).
  • the elongated tubes used the present invention are filled with a rare gas, such as argon, and a drop of mercury.
  • the vitreous tubes can have an outer periphery which is smooth or include a helical groove path formed therein over at least a portion of its axial length, similar to the lamps disclosed in U.S. Patent Nos. 6,943,361 and 6,777,702, which are herein incorporated by reference in their entirety.
  • the phosphor coating can be applied to the lamp in a single coating with the desired chemical composition or a multi-layer coating, as know to those skilled in the art. Additionally, the coating(s) can be applied along the entire length of the lamp or over a portion of the length, as described in U.S.
  • Patent 6,919,676 which is herein incorporated by reference in its entirety.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Radiation-Therapy Devices (AREA)
EP07837496A 2006-08-31 2007-08-29 Lampe zur stimulierung der produktion von vitamin d und verfahren zu ihrer herstellung Withdrawn EP2069015A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84161506P 2006-08-31 2006-08-31
PCT/US2007/019010 WO2008027438A2 (en) 2006-08-31 2007-08-29 Lamp for stimulating vitamin d production and method of making the same

Publications (1)

Publication Number Publication Date
EP2069015A2 true EP2069015A2 (de) 2009-06-17

Family

ID=39136566

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07837496A Withdrawn EP2069015A2 (de) 2006-08-31 2007-08-29 Lampe zur stimulierung der produktion von vitamin d und verfahren zu ihrer herstellung

Country Status (2)

Country Link
EP (1) EP2069015A2 (de)
WO (1) WO2008027438A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010016009A1 (en) * 2008-08-07 2010-02-11 Koninklijke Philips Electronics N.V. Ultra-violet and visible light emitting system
DK2500060T3 (en) 2011-03-17 2016-12-19 Jk-Holding Gmbh An apparatus for irradiation with actinic radiation of different wavelengths
EP2573799A1 (de) * 2011-09-21 2013-03-27 SRLight ApS Vorrichtung zur Förderung der Produktion von Vitamin D in einem lebenden Organismus
KR101322658B1 (ko) * 2011-11-24 2013-10-30 주식회사 루트로닉 의료용 레이저 치료장치
WO2013103743A1 (en) * 2012-01-03 2013-07-11 Moffat William A Phototherapeutic apparatus for focused uvb radiation and vitamin d synthesis and associated systems and methods
CA2928723A1 (en) 2013-10-25 2015-04-30 Benesol, Inc. Systems and methods for increased vitamin d3 production
CN105470069B (zh) * 2015-10-23 2017-10-17 东台市天源荧光材料有限公司 一种uvb太阳光补钙荧光灯的制备方法
US20200391049A1 (en) 2017-12-15 2020-12-17 Benesol, Inc. Systems and methods for operating phototherapy kiosks
US11350496B2 (en) 2019-02-19 2022-05-31 Seoul Semiconductor Co., Ltd. LED lighting apparatus and lighting system having the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609273A1 (de) * 1976-03-05 1977-09-08 Mutzhas Maximilian F Bestrahlungseinrichtung mit ultraviolett-strahlenquelle
US6447537B1 (en) * 2000-06-21 2002-09-10 Raymond A. Hartman Targeted UV phototherapy apparatus and method
US7144248B2 (en) * 2001-10-18 2006-12-05 Irwin Dean S Device for oral UV photo-therapy
JP2003194721A (ja) * 2001-12-26 2003-07-09 Nec Lighting Ltd 蛍光トランスイルミネーター

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008027438A3 *

Also Published As

Publication number Publication date
WO2008027438A3 (en) 2008-06-19
WO2008027438A2 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
EP2069015A2 (de) Lampe zur stimulierung der produktion von vitamin d und verfahren zu ihrer herstellung
EP2968972B1 (de) Quantenpunkt-leuchtdioden für eine lichttherapie
US3670193A (en) Electric lamps producing energy in the visible and ultra-violet ranges
EP1970423A1 (de) Leuchtstofflampe zur Anregung der Bildung von Prävitamin D3
EP2164566B1 (de) Hautbehandlungsvorrichtung, lampe
Willis et al. The rapid induction of cancers in the hairless mouse utilizing the principle of photoaugmentation
Diffey Ultraviolet radiation physics and the skin
US4959551A (en) Cosmetic tanning lamp and system having adjustable UVB proportion
US20080039907A1 (en) Phototherapy Systems and Methods
NO852864L (no) Lysstofflampe.
Morita et al. Short-range ultraviolet irradiation with LED device effectively increases serum levels of 25 (OH) D
Hemne et al. Phosphor for phototherapy: review on psoriasis
National Toxicology Program Ultraviolet-radiation-related exposures
EP1523760B1 (de) Bräunungsgerät
Belsare et al. Preparation and characterization of uv emitting fluoride phosphors for phototherapy lamps
EP2023374A2 (de) UV-Bräunungslampe mit gesteuerter Bestrahlung
EP3456380A1 (de) Zur aussendung von strahlung im uv-b-wellenlängenbereich fähiges material
US20080255547A1 (en) Uv Lamp for Treatment of the Skin
Farr et al. Phototherapy and dithranol treatment of psoriasis: new lamps for old.
Jekler et al. Ultraviolet radiation dosimetry in phototherapy for atopic dermatitis
McKenzie et al. Sunburn versus vitamin D induced by UV from solaria and sunlight in New Zealand
Coblentz The physical aspects of ultraviolet therapy
JPS63136457A (ja) 健康増進用蛍光ランプ
Wanmaker et al. New blue lamp for phototherapy of hyperbilirubinemia
WO2023244558A1 (en) Ultraviolet b lighting system and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BATCHOS, DENNIS L.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110201